Cargando…
The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis
BACKGROUND: Standard treatment for high-grade glioma (HGG) includes surgery followed by radiotherapy and/or chemotherapy. Insertion of carmustine wafers into the resection cavity as a treatment for malignant glioma is currently a controversial topic among neurosurgeons. Our meta-analysis focused on...
Autores principales: | Xing, Wei-kang, Shao, Chuan, Qi, Zhen-yu, Yang, Chao, Wang, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492653/ https://www.ncbi.nlm.nih.gov/pubmed/26170620 http://dx.doi.org/10.2147/DDDT.S85943 |
Ejemplares similares
-
Gliadel wafers in the treatment of malignant glioma: a systematic review
por: Perry, J., et al.
Publicado: (2007) -
Interstitial chemotherapy with biodegradable BCNU (Gliadel(®)) wafers in the treatment of malignant gliomas
por: Bota, Daniela A, et al.
Publicado: (2007) -
Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review
por: Ashby, Lynn S., et al.
Publicado: (2016) -
In vitro Study of Serial Changes to Carmustine Wafers (Gliadel) with MR Imaging and Computed Tomography
por: Doishita, Satoshi, et al.
Publicado: (2017) -
Gliadel for brain metastasis
por: Abel, Taylor J., et al.
Publicado: (2013)